A.J. Rice
Stock Analyst at UBS
(4.19)
# 375
Out of 5,174 analysts
272
Total ratings
58.76%
Success rate
10.17%
Average return
Main Sectors:
Stocks Rated by A.J. Rice
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BTSG BrightSpring Health Services | Maintains: Buy | $53 → $55 | $43.31 | +26.99% | 7 | Mar 18, 2026 | |
| MOH Molina Healthcare | Maintains: Neutral | $145 → $151 | $141.74 | +6.53% | 4 | Mar 12, 2026 | |
| SGRY Surgery Partners | Maintains: Buy | $29 → $21 | $12.00 | +75.00% | 3 | Mar 5, 2026 | |
| PACS PACS Group | Maintains: Buy | $42 → $44 | $33.71 | +30.53% | 3 | Mar 4, 2026 | |
| MD Pediatrix Medical Group | Maintains: Neutral | $23 → $22 | $20.75 | +6.02% | 20 | Feb 24, 2026 | |
| EHAB Enhabit | Downgrades: Neutral | $12 → $14 | $13.66 | +1.02% | 5 | Feb 24, 2026 | |
| CYH Community Health Systems | Maintains: Neutral | $3.6 → $3.7 | $2.92 | +26.71% | 9 | Feb 20, 2026 | |
| AMN AMN Healthcare Services | Maintains: Neutral | $19 → $20 | $18.49 | +5.46% | 12 | Feb 20, 2026 | |
| THC Tenet Healthcare | Maintains: Buy | $260 → $288 | $199.63 | +44.27% | 13 | Feb 12, 2026 | |
| HUM Humana | Maintains: Neutral | $285 → $195 | $172.23 | +13.22% | 10 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $430 → $410 | $272.28 | +50.58% | 13 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9.5 → $10 | $6.61 | +51.29% | 13 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $14 | $8.59 | +62.98% | 2 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $17 → $9 | $9.75 | -7.69% | 10 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $205 → $220 | $202.92 | +8.42% | 4 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $31 → $42 | $32.98 | +27.35% | 20 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $302 | $185.92 | +62.44% | 17 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $22 | $19.39 | +13.46% | 12 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $95 | $77.48 | +22.61% | 13 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $150 | $97.49 | +53.86% | 9 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $435 → $425 | $290.33 | +46.39% | 5 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $145 | $99.31 | +46.01% | 1 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $14 | $16.27 | -13.95% | 8 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $68 | $52.90 | +28.54% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $38 → $40 | $28.41 | +40.80% | 2 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $450 → $485 | $881.94 | -45.01% | 1 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $95 | $22.69 | +318.69% | 13 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $311 → $316 | $485.72 | -34.94% | 12 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $96 | $72.80 | +31.87% | 6 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $308 → $305 | $266.12 | +14.61% | 4 | Nov 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $64 → $79 | $207.23 | -61.88% | 3 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $158 → $143 | $196.08 | -27.07% | 9 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $270 | $265.87 | +1.55% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $0.57 | $19.77 | -97.12% | 3 | Jan 25, 2021 |
BrightSpring Health Services
Mar 18, 2026
Maintains: Buy
Price Target: $53 → $55
Current: $43.31
Upside: +26.99%
Molina Healthcare
Mar 12, 2026
Maintains: Neutral
Price Target: $145 → $151
Current: $141.74
Upside: +6.53%
Surgery Partners
Mar 5, 2026
Maintains: Buy
Price Target: $29 → $21
Current: $12.00
Upside: +75.00%
PACS Group
Mar 4, 2026
Maintains: Buy
Price Target: $42 → $44
Current: $33.71
Upside: +30.53%
Pediatrix Medical Group
Feb 24, 2026
Maintains: Neutral
Price Target: $23 → $22
Current: $20.75
Upside: +6.02%
Enhabit
Feb 24, 2026
Downgrades: Neutral
Price Target: $12 → $14
Current: $13.66
Upside: +1.02%
Community Health Systems
Feb 20, 2026
Maintains: Neutral
Price Target: $3.6 → $3.7
Current: $2.92
Upside: +26.71%
AMN Healthcare Services
Feb 20, 2026
Maintains: Neutral
Price Target: $19 → $20
Current: $18.49
Upside: +5.46%
Tenet Healthcare
Feb 12, 2026
Maintains: Buy
Price Target: $260 → $288
Current: $199.63
Upside: +44.27%
Humana
Feb 12, 2026
Maintains: Neutral
Price Target: $285 → $195
Current: $172.23
Upside: +13.22%
Jan 28, 2026
Maintains: Buy
Price Target: $430 → $410
Current: $272.28
Upside: +50.58%
Jan 15, 2026
Maintains: Neutral
Price Target: $9.5 → $10
Current: $6.61
Upside: +51.29%
Dec 18, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $8.59
Upside: +62.98%
Dec 9, 2025
Maintains: Neutral
Price Target: $17 → $9
Current: $9.75
Upside: -7.69%
Nov 5, 2025
Maintains: Buy
Price Target: $205 → $220
Current: $202.92
Upside: +8.42%
Oct 30, 2025
Maintains: Neutral
Price Target: $31 → $42
Current: $32.98
Upside: +27.35%
Oct 29, 2025
Maintains: Buy
Price Target: $280 → $302
Current: $185.92
Upside: +62.44%
Oct 28, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $19.39
Upside: +13.46%
Oct 13, 2025
Maintains: Buy
Price Target: $88 → $95
Current: $77.48
Upside: +22.61%
Oct 2, 2025
Maintains: Buy
Price Target: $140 → $150
Current: $97.49
Upside: +53.86%
Sep 5, 2025
Maintains: Buy
Price Target: $435 → $425
Current: $290.33
Upside: +46.39%
Sep 2, 2025
Initiates: Buy
Price Target: $145
Current: $99.31
Upside: +46.01%
Aug 4, 2025
Maintains: Neutral
Price Target: $15 → $14
Current: $16.27
Upside: -13.95%
May 5, 2025
Maintains: Neutral
Price Target: $80 → $68
Current: $52.90
Upside: +28.54%
Apr 30, 2025
Upgrades: Buy
Price Target: $38 → $40
Current: $28.41
Upside: +40.80%
Aug 11, 2023
Maintains: Outperform
Price Target: $450 → $485
Current: $881.94
Upside: -45.01%
Jul 31, 2023
Reiterates: Outperform
Price Target: $95
Current: $22.69
Upside: +318.69%
Jul 28, 2023
Maintains: Outperform
Price Target: $311 → $316
Current: $485.72
Upside: -34.94%
May 8, 2023
Maintains: Outperform
Price Target: $125 → $96
Current: $72.80
Upside: +31.87%
Nov 23, 2022
Maintains: Outperform
Price Target: $308 → $305
Current: $266.12
Upside: +14.61%
Nov 22, 2022
Maintains: Neutral
Price Target: $64 → $79
Current: $207.23
Upside: -61.88%
Jul 22, 2022
Maintains: Neutral
Price Target: $158 → $143
Current: $196.08
Upside: -27.07%
Aug 6, 2021
Maintains: Outperform
Price Target: $300 → $270
Current: $265.87
Upside: +1.55%
Jan 25, 2021
Downgrades: Underperform
Price Target: $0.57
Current: $19.77
Upside: -97.12%